Home
Biognosys

Biognosys Market Share Analysis for August 2026

For retention time normalization and LC-MS quality control use our iRT Kit. Indexed Retention Time makes data comparable across chromatography methods.

Science and Education > Biology

Domainbiognosys.com

Year Founded2008

Employees51 - 200

Annual Revenue$2M - $5M

Biognosys

Biognosys (including company regionals)

biognosys.com

See more website traffic and engagement information

Biognosys Revenue up to August 2026 is 2M - 5M

revenue generated by Biognosys top domains

Biognosys top domains revenue over 3 years

Revenue for Biognosys top domains

biognosys.com2M - 5M

See more with Sales Intelligence

Total visits to Biognosys's top domains

Understand Biognosys market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

biognosys.com15.2K

See more with Sales Intelligence

Avg. visit duration in Biognosys's top domains

Analyze Biognosys engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

biognosys.com00:00:11

See more with Sales Intelligence

Avg. pageviews on Biognosys's top domains

See how Biognosys keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

biognosys.com1.78

See more with Sales Intelligence

Biognosys top competitors by domain

Top similar sites in August 2026, ranked by their affinity

proteinmetrics.comCompany NameProtein MetricsEmployees51 - 200HQUnited States, California, CupertinoAnnual revenue$2M - $5MTotal visits3.9KScience and Education > Biology

Top technologies used by Biognosys

These are the website technologies, by industry, used by Biognosys top domains

Advertising (6)

Google Adsense

Conversion & Analytics (6)

Google Analytics

Marketing (4)

Google Marketing Platform

Payment & Currencies (4)

Cart Functionality

More Technologies

12

See all

News & Signals from Biognosys

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsBiognosys AG is developing sensitive and quantitative biomarker assays for Parkinson's disease.Biognosys Group and The Michael J. Fox Foundation for Parkinson's Research (MJFF) have announced a collaboration to develop sensitive and quantitative biomarker assays for Parkinson's disease.

NewsBiognosys AG partnered with The Michael J. Fox Foundation on Apr 14th '26.April 14, 2026 - ZURICH, Switzerland - Life Science Newswire - Biognosys Group, a leading provider of proteomics, metabolomics, and lipidomics solutions, today announced a major collaboration with The Michael J. Fox Foundation for Parkinson's Research (MJFF) to advance the development of highly sensitive and quantitative biomarker assays for Parkinson's disease.

NewsBiognosys AG is developing targeted proteomic assays.Together, Biognosys AG developed targeted proteomic assays to directly monitor the degradation of specific proteins induced by their drug candidates.